TABLE 1—

Self-Reported HIV Testing and Prevalence Among Urban Intravenous Drug Users in 5 Cities: 1998–2002

	Oakland, Calif n = 163	Chicago, Ill n = 289	Hartford, Conn n = 440	New Haven, Conn n = 320	Springfield, Mass n = 331
Ever tested, n (%)	151 (92.6)	255 (88.2)	418 (95.0)	300 (93.8)	306 (92.4)
HIV+, n (% of ever tested)	4 (2.7)	27 (10.6)	102 (24.4)	69 (23.0)	98 (32.0)
Seronegative, na	147	228	316	231	208
Tested previous year, n (%)b	110 (74.8)	159 (69.7)	248 (78.5)	139 (60.1)	120 (57.7)
Tested previous 3 years, n (%)b	131 (89.1)	213 (93.4)	296 (93.7)	200 (86.6)	172 (82.7)

^aThe number of intravenous drug users who reported being tested for HIV and did not report being told that they were HIV seropositive.

^bThe number and percent among tested, non–HIV-positive intravenous drug users.